Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Moderna

Growth Stocks Are Back — Analysts Like These 8 The Best

Growth stocks in the S&P 500 are racing back. And analysts are scrambling to choose their favorites.

Investors Business Daily

Scottish Mortgage sees share price fall by a third

Net asset value also fell by more than 17% during a year that has been 'painful for shareholders'

Insider UK

These Next-Generation Vaccines Could Upend Cancer Treatment As We Know It

New high-tech vaccines could help combat common yet deadly conditions like cancer and heart disease.

Inverse

From analysis to the latest developments in health,
read the most diverse news in one place.

The Vaccine Problem

To better weather future pandemics, the way countries procure vaccines needs to change radically

The Walrus

mRNA technology beat COVID-19, can it do the same for pancreatic cancer?

Half the pancreatic cancer patients in a new clinical trial were alive and cancer free after 18 months. Most usually die within three months.

The New Daily

FDA approves first vaccine for respiratory syncytial virus

The FDA has approved the first vaccine for respiratory syncytial virus (RSV).

The Hindu

Moderna Stock Pops on Surprise Earnings Beat

An unexpected profit and promising news on a deal with the EU boosted Moderna stock.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

Moderna Jumps On Unexpected First-Quarter Profit Amid Plummeting Covid Sales

Moderna stock jumped Thursday on an unexpected first-quarter gain even as sales plummeted amid waning demand for Covid vaccines.

Investors Business Daily

US becomes first country to approve RSV vaccine

Washington (AFP) - The United States on Wednesday approved the world's first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades-long hunt to protect vulnerable people from the common illness.

AFP

US issues world's first approval of RSV vaccine

Washington (AFP) - The United States on Wednesday approved the world's first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades long hunt to protect vulnerable people from the common illness.

AFP

GSK Stock Jumps After Beating Pfizer, Moderna To The RSV Vaccine Finish Line

GSK stock jumped Wednesday after the drugmaker won the first-ever approval for an RSV vaccine, leading rivals Pfizer and Moderna.

Investors Business Daily

Attorney General Ken Paxton to investigate COVID-19 vaccine makers

Long an opponent of vaccine and mask mandates, the Republican said pharmaceutical companies may have misrepresented data. Pfizer strongly disagrees.

The Texas Tribune

Lyme disease: vaccine could halt rise of tick-borne disease

A vaccine for Lyme disease could be available soon, according to reports.

The Week

Moderna's CEO shares what it was like to leap from pre-revenue startup to Fortune 500 company

The COVID-19 vaccine turned Moderna into a household name. What's next for the company?

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

AFP

Scientists develop mobile printer for mRNA vaccine patches

Paris (AFP) - Scientists said Monday they have developed the first mobile printer that can produce thumbnail-sized patches able to deliver mRNA Covid vaccines, hoping the tabletop device will help immunise people in remote regions.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Investors Business Daily

Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review

The major indexes saw modest declines, holding in a range. Tesla sold off as gross margins plunged. ISRG and DHI were earnings winners.

Investors Business Daily

Novavax Plummets On Downgrade: Is It The Covid Engine That Couldn't?

Novavax has a solid platform but continues to face a $700 million litigation headwind, an analyst said Thursday as he downgraded NVAX stock.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Bearish Option Trade For MRNA Stock

With low implied volatility right now, a bear put spread on Moderna is a viable strategy to profit on the downside.

The Independent UK

Extra spring COVID booster cleared for certain Americans

Certain Americans at high risk from COVID-19 can get an extra vaccine booster this spring

Investors Business Daily

S&P 500: Top 5 Performers Today Include Enphase Energy, First Solar

The five best S&P 500 performers Monday included Enphase Energy and First Solar. Moderna was a key laggard. Banks were big winners and losers.

Investors Business Daily

Moderna Crumbles As Cancer Vaccine Data Show A 'Longish And Complex' Road

Moderna stock crumbled Monday after updated results for its Merck-partnered cancer vaccine show a "longish and complex path" toward approval.

Investors Business Daily

Stock Market Slides After Mixed Bank Earnings, Meta Downgrade, Google's AI Trauma

Google parent Alphabet sold off more than 3% after Samsung considered ditching the search engine.

Evening Standard

Autumn Covid booster 2023: Who is eligible for another jab?

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

The Week

Sanofi: the new protein-based Covid vaccine to be used in the UK

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.